Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene

Oncogene

Volumn 22, Issue 25, 2003, Pages 3911-3916

  Paterlini Bréchot, Patrizia ^a   Saigo, Kenichi ^b   Murakami, Yoshiki ^a   Chami, Mounia ^a   Gozuacik, Devrim ^a   Mugnier, Claude ^a   Lagorce, David ^c   Bréchot, Christian ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Necker Enfants Matades Hospital ^*

Author keywords

Hepatitis B Virus; Hepatocellular carcinoma; hTERT; Insertional mutagenesis

Indexed keywords

ALPHA 2,3 SIALYLTRANSFERASE; GENE PRODUCT; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUROTROPHIC TYROSINE RECEPTOR KINASE 2; TELOMERASE; THYROID HORMONE UNCOUPLING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; DNA INTEGRATION; GENE INSERTION; GENE MUTATION; GENE TARGETING; HEPATITIS B VIRUS; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME;

CALCIUM CHANNELS; CALCIUM-TRANSPORTING ATPASES; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; DNA, VIRAL; DNA-BINDING PROTEINS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIVER NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MUTAGENESIS, INSERTIONAL; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN KINASES; RECEPTOR, TRKB; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RIBOSOMAL PROTEINS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIALYLTRANSFERASES; TELOMERASE; TRANSCRIPTION FACTORS; VIRUS INTEGRATION;

DNA VIRUSES; HEPATITIS B VIRUS; INSERTION SEQUENCES;

EID: 0037663314     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206492     Document Type: Article

References (40)

1. Berasain C, Patil D, Perara E, Huang SM, Mouly H and Brechot C. (1998). Oncogene, 16, 1277-1288.
2. Brechot C, Gozuacik D, Murakami Y and Paterlini-Brechot P. (2000). Semin. Cancer Biol., 10, 211-231.
3. Buendia MA. (1992). Semin. Cancer Biol., 3, 309-320.
4. Burris TP, Nawaz Z, Tsai MJ and O'Malley BW. (1995). Proc. Natl. Acad. Sci. USA, 92, 9525-9529.
5. Chami M, Gozuacik D, Saigo K, Capiod T, Falson P, Lecoeur H, Urashima T, Beckmann J, Gougeon ML, Claret M, Maire M, Brechot C and Paterlini-Brechot P. (2000). Oncogene, 19, 2877-2886.
6. Corcoran L, Adams J, Dunn A and Cory S. (1984). Cell, 37, 113-122.
7. Dejean A, Bougueleret L, Grzeschik KH and Tiollais P. (1986). Nature, 322, 70-72.
8. Fourel G, Couturier J, Wei Y, Apiou F, Tiollais P and Buendia M. (1994). EMBO J., 13, 2526-2534.
9. Fourel G, and Tiollais P. (1994). Primary Liver Cancer: Etiological and Progression Factors. CB. (ed). CRC Press: Boca Raton, FL, pp 89-123.
10. Garcia M, De Thé H, Tiollais P, Samarut J and Dejean A. (1993). Cell Biol., 90, 89-93.
11. Gozuacik D, Murakami Y, Saigo K, Chami M, Mugnier C, Lagorce D, Okanoue T, Urashima T, Bréchot C and Paterlini-Bréchot P. (2001). Oncogene, 20, 6233-6240.
12. Graef E, Caselmann WH, Wells J and Koshy R. (1994). Oncogene, 9, 81-87.
13. Hanahan D and Weinberg RA. (2000). Cell, 100, 57-70.
14. Horikawa I and Barrett J. (2001). J. Natl. Cancer Inst., 93, 1171-1173.
15. Kroes RA, Jastrow A, McLone MG, Yamamoto H, Colley P, Kersey DS, Yong VW, Mkrdichian E, Cerullo L, Leestma J and Moskal JR. (2000). Cancer Lett., 156, 191-198.
16. MacDonald T, Brown K, LaFleur B, Peterson K, Lawlor C, Chen Y, Packer R, Cogen P and Stephan D. (2001). Nat. Genet., 29, 143-152.
17. Matsubara K and Tokino T. (1990). Mol. Biol. Med., 7, 243-260.
18. Meyerson M. (2000). J. Clin. Oncol., 18, 2626-2634.
19. Minami M, Poussin K, Brechot C and Paterlini P. (1995). Genomics, 29, 403-408.
20. Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T and Kajiyama G. (1997). Int. J. Cancer, 74, 141-147.
21. Nusse R and Varmus H. (1982). Cell, 31, 99-109.
22. Palsson McDermott E and O'Neill L. (2002). J. Biol. Chem., 277, 7808-7815.
23. Payne G, Bishop J and Varmus H. (1982). Nature, 21, 209-214.
24. Petretti T, Kemmner W, Schulze B and Schlag PM. (2000). Gut, 46, 359-366.
25. Pozzan T, Rizzuto R, Volpe P and Meldolesi J. (1994). Physiol. Rev., 74, 595-636.
26. Robinson WS, Miller RH and Marion PL. (1987). Hepatology, 7, 64S-73S.
27. Russo G, Ricciardelli G and Pietropaolo C. (1997). J. Biol. Chem., 272, 5229-5235.
28. Scherdin U, Rhodes K and Breindl M. (1990). J. Virol., 64, 907-912.
29. Schneider F, Kemmner W, Haensch W, Franke G, Gretschel S, Karsten U and Schlag PM. (2001). Cancer Res., 61, 4605-4611.
30. Schröder ARW, Shinn P, Chen H, Berry C, Ecker JR and Bushman F. (2002). Cell, 110, 521-529.
31. Shibayama E and Koizumi H. (1996). Am. J. Pathol., 148, 1807-1818.
32. Sugimoto T, Kuroda H, Horii Y, Moritake H, Tanaka T and Hattori S. (2001). Jpn J. Cancer Res., 92, 152-160.
33. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay J, Tahara E, Kajiyama G and Ide T. (1995). Cancer Res., 55, 2734-2736.
34. Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C and Kremsdorf D. (2001). Cancer Res., 61, 7803-7810.
35. Urashima T, Saigo K, Kobayashi S, Imaseki H, Matsubara H, Koide Y, Asano T, Kondo Y, Koike K and Isono K. (1997). J. Hepatol., 26, 771-778.
36. Wang J, Chenivesse X, Henglein B and Brechot C. (1990). Nature, 343, 555-557.
37. Wang Y, Cheong D, Chan S and Hooi SC. (2000). Int. J. Oncol., 16, 757-762.
38. Weber G, Shen F, Prajda N, Yeh Y, Yang H, Herenyiova M and Look K. (1996). Anticancer Res., 16, 3271-3282.
39. Yu C, Montoya D, Smith DI and Roberts LR. (2002). 93rd Annual Meeting of American Association for Cancer Research (AACR), Vol. 43. Proceedings. CR. (ed). The American Association for Cancer Research: San Francisco, CA, USA.
40. Zhu Y, Srivatana U, Ullah A, Gagneja H, Berenson CS and Lance P. (2001). Biochim. Biophys. Acta, 1536, 148-160.